FDA updates labeling for PROSTIN VR PEDIATRIC FDA Approval Dec. 31, 2025, 13:45 UTC Labeling changes approved for PFIZER. Active ingredient: ALPROSTADIL. Decision date: 12/22/2025 Full text
There are no comments here yet...